查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1568043

世界人工心臟市場

Artificial Hearts
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到2030年全球人工心臟市場將達47億美元

2023年全球人造心臟市場預估為24億美元，預估至2030年將達47億美元，2023-2030年分析期間複合年成長率為10.1%。左心室輔助裝置是本報告分析的細分市場之一，預計複合年成長率為 9.8%，到分析期結束時將達到 36 億美元。在分析期間，整個人造心臟市場的複合年成長率預計為 12.7%。

美國市場預估為6.587億美元，中國預期複合年成長率為13.7%

預計 2023 年美國人工心臟市場規模將達 6.587 億美元。中國作為世界第二大經濟體，預計2023年至2030年複合年成長率為13.7%，到2030年市場規模將達到9.998億美元。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 7.5% 和 8.7%。在歐洲，德國預計複合年成長率為 7.9%。

全球人造心臟市場－主要趨勢與促進因素總結

為什麼人造心臟會徹底改變心臟病領域？

人造心臟已成為心臟病學領域的突破性創新，為在傳統治療效果不佳的情況下患有終末期心臟衰竭和嚴重心臟疾病的患者提供了挽救生命的解決方案。但到底什麼是人工心臟呢？為什麼它對現代醫學至關重要？傳統的機械心臟幫浦和輔助人工心臟（VAD）用於支持衰竭的心臟，而全人工心臟（TAH）則旨在完全取代心臟的自然功能，它旨在接管兩個心室的工作以循環血液。全身。這對於因年齡、缺乏合適的捐贈者或無法進行傳統手術的併發症而不合格心臟移植的患者尤其重要。透過完全複製人類心臟的功能，人造心臟可以作為移植或永久替代的橋樑，為選擇有限的人帶來希望。人工心臟的設計和應用自誕生以來已經發生了巨大的發展，結合了生物相容性材料和先進的感測器來降低血液凝固的風險並提高血液動力學穩定性。如今，人造心臟不再被認為是實驗性的，而是心臟外科醫生套件包中的一個可行選擇，可顯著提高患者的生存率和生活品質。

推動人工心臟發展的主要技術創新有哪些？

人造心臟的發展是由最尖端科技和生物工程進步的融合所推動的，這些進步將這些設備從基本的機械泵轉變為複雜的生命維持系統。最重要的創新之一是採用仿生設計，可以對人造心臟進行建模，以複製人類心臟的自然脈動流動，消除血栓症和溶血等併發症，降低風險。這種設計是透過先進的計算模型和 3D 列印技術實現的，工程師可以微調人造心臟的形狀和功能，以適應每個患者的個人解剖結構。另一個關鍵進步是智慧感測器和即時監測系統的整合，這使得人造心臟能夠根據身體不斷變化的需求（例如在身體活動或休息期間）自動調整血流量。這種適應性對於心臟健康以及確保其能夠響應生理需求非常重要。此外，電池技術的進步正在延長人造心臟的使用壽命和便攜性，減少頻繁更換的需要並增加患者的活動能力。聚合物和鈦合金等生物相容性材料的創新也最大限度地減少了免疫反應並提高了這些設備的長期耐用性。此外，研究人員正在探索使用無線能量傳輸和不需要外部組件的完全植入式人工心臟，從而降低感染風險。

人造心臟如何改善病人預後和生活品質？

人造心臟的出現極大地改善了患者的預後，並為因嚴重心臟病而面臨高死亡率的人們帶來了新的生命。對於等待心臟移植的患者來說，人造心臟可以為移植提供重要的橋樑，在等待合適的捐贈器官的同時穩定和增強他們的健康。當無法進行心臟移植時，人造心臟提供了永久的解決方案，使患者能夠過著相對正常的生活。全替代人工心臟（TAH）的引入尤其具有影響力，因為它們可以完全接管心臟的功能並支持全身的血液循環和氧合。與前身相比，現代人造心臟更小、更節能、更易於使用，為患者提供了更多的自由度和活動性。臨床資料表明，使用人工心臟可顯著提高高風險患者的存活率，減少再入院率，並有助於改善長期健康結果。此外，人造心臟的設計旨在最大限度地減少先前模型中常見的併發症，例如血栓形成和裝置故障。這是透過仔細的設計改進來實現的，包括光滑的表面和先進的抗凝血管理系統，以減少對血球的損害。另外值得注意的是，患者及其家人的心理益處是減少焦慮並提高安全感，因為他們知道設備可以自主適應他們身體的需求。隨著這些設備的不斷發展，心臟衰竭患者不僅會活得更長，而且會重新獲得更高的生活品質。

推動人工心臟市場成長的因素有哪些？

人造心臟市場的成長是由幾個因素推動的，這些因素主要受醫療技術進步、心臟疾病患病率增加和不斷變化的醫療保健政策的影響。主要因素之一是末期心臟衰竭和其他嚴重心臟疾病的盛行率不斷上升，隨著世界人口老化，迫切需要替代治療方案。這種趨勢因捐贈心臟的長期短缺而加劇，等待名單往往長達數年，許多患者在合適的器官出現之前就去世了。因此，人造心臟擴大被用作移植之前的橋樑，或作為不適合心臟移植的患者的目標治療。另一個重要的驅動力是生物工程和材料科學的快速創新，導致更耐用、生物相容性和高效的人造心臟模型的開發。這些技術進步使人造心臟更安全、更容易取得，不僅在學術研究中心，而且在世界各地的各種醫療機構中擴大了其用途。此外，公營和私營部門對研發的投資增加正在加速人工心臟的商業化和臨床應用。此外，醫療保健支出的增加和對先進心臟治療方案的認知不斷提高，正在推動這些尖端設備在醫院中的採用，進一步推動市場需求。遠端醫療和遠端監測技術的擴展也是增加人工心臟吸引力的因素之一。這些解決方案能夠即時追蹤設備性能和患者健康狀況，減少併發症並改善整體患者管理。這些促進因素正在推動人造心臟市場的成長，並將人造心臟定位為未來心血管治療的關鍵組成部分，並為嚴重心臟病患者帶來一線希望。

受訪企業範例（43家知名企業）

  • Abbott Laboratories, Inc.
  • Abiomed, Inc.
  • Artivion, Inc
  • Berlin Heart GmbH
  • BiVACOR, Inc.
  • Boston Scientific Corporation
  • Calon Cardio-Technology Ltd.
  • CARMAT
  • Edwards Lifesciences Corporation
  • Jarvik Heart, Inc.

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 比賽

簡介目錄
Product Code: MCP24104

Global Artificial Hearts Market to Reach US$4.7 Billion by 2030

The global market for Artificial Hearts estimated at US$2.4 Billion in the year 2023, is expected to reach US$4.7 Billion by 2030, growing at a CAGR of 10.1% over the analysis period 2023-2030. Left Ventricular Assist Devices, one of the segments analyzed in the report, is expected to record a 9.8% CAGR and reach US$3.6 Billion by the end of the analysis period. Growth in the Total Artificial Heart segment is estimated at 12.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$658.7 Million While China is Forecast to Grow at 13.7% CAGR

The Artificial Hearts market in the U.S. is estimated at US$658.7 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$999.8 Million by the year 2030 trailing a CAGR of 13.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.5% and 8.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.9% CAGR.

Global Artificial Hearts Market - Key Trends and Drivers Summarized

Why Are Artificial Hearts Revolutionizing the Field of Cardiology?

Artificial hearts have emerged as a groundbreaking innovation in the field of cardiology, providing life-saving solutions for patients suffering from end-stage heart failure or severe cardiac conditions where conventional treatments are insufficient. But what exactly are artificial hearts, and why are they so critical to modern medicine? Unlike traditional mechanical heart pumps or ventricular assist devices (VADs), which are used to support a failing heart, total artificial hearts (TAHs) are designed to entirely replace the heart's natural function, taking over the job of both ventricles to circulate blood throughout the body. This is particularly important for patients who are ineligible for heart transplants due to age, lack of suitable donors, or complications that preclude traditional surgeries. By replicating the full functionality of a human heart, artificial hearts provide a bridge-to-transplant solution or serve as a permanent replacement, offering hope to those who would otherwise face limited options. The design and application of artificial hearts have evolved dramatically since their inception, incorporating biocompatible materials and advanced sensors to reduce clotting risks and improve hemodynamic stability. Today, artificial hearts are no longer considered experimental but are viewed as viable options in the toolkit of cardiac surgeons, significantly enhancing patient survival rates and quality of life.

What Are the Major Technological Innovations Driving Artificial Heart Development?

The development of artificial hearts is being propelled by a confluence of cutting-edge technologies and bioengineering advancements that are transforming these devices from rudimentary mechanical pumps into sophisticated, life-sustaining systems. One of the most significant innovations is the use of biomimetic designs, where artificial hearts are modeled to replicate the natural pulsatile flow of a human heart, reducing the risk of complications like thrombosis and hemolysis. These designs are achieved through the use of advanced computational models and 3D printing technologies, allowing engineers to fine-tune the shape and function of artificial hearts to match individual patient anatomies. Another pivotal advancement is the integration of smart sensors and real-time monitoring systems, which enable artificial hearts to automatically adjust blood flow based on the body’s changing needs, such as during physical activity or rest. This adaptability is critical for ensuring that the device can respond to physiological demands in a manner similar to a healthy heart. Additionally, progress in battery technology is extending the lifespan and portability of artificial hearts, reducing the need for frequent replacements and enhancing patient mobility. Innovations in biocompatible materials, such as polymers and titanium alloys, are also minimizing immune responses and improving the long-term durability of these devices. Furthermore, researchers are exploring the use of wireless energy transfer and fully implantable artificial hearts that eliminate the need for external components, thereby reducing infection risks.

How Are Artificial Hearts Enhancing Patient Outcomes and Quality of Life?

The advent of artificial hearts is dramatically enhancing patient outcomes, providing a new lease on life for individuals who would otherwise face high mortality rates due to severe cardiac conditions. For patients awaiting heart transplants, artificial hearts offer a crucial bridge-to-transplant option, allowing them to stabilize and strengthen their health while waiting for a suitable donor organ. In cases where a heart transplant is not feasible, artificial hearts can serve as a permanent solution, enabling patients to lead relatively normal lives. The introduction of total artificial hearts (TAHs) has been particularly impactful, as these devices can completely take over cardiac function, supporting blood circulation and oxygenation throughout the body. Compared to earlier iterations, modern artificial hearts are significantly more compact, energy-efficient, and user-friendly, allowing patients greater freedom and mobility. Clinical data has shown that the use of artificial hearts can significantly improve survival rates in high-risk patients and reduce hospital readmissions, contributing to better long-term health outcomes. Additionally, artificial hearts are engineered to minimize complications such as blood clot formation and device failure, which were common issues in earlier models. This is achieved through meticulous design improvements, including smoother surfaces to reduce blood cell damage and advanced anticoagulation management systems. Psychological benefits are also notable, as patients and their families experience reduced anxiety and an improved sense of security knowing that the device is capable of autonomously adapting to the body’s needs. As these devices continue to evolve, they are not only extending life expectancy for heart failure patients but also restoring a higher quality of life.

What Factors Are Driving the Growth of the Artificial Hearts Market?

The growth in the artificial hearts market is driven by several factors, primarily influenced by advancements in medical technology, a growing prevalence of heart disease, and evolving healthcare policies. One of the main drivers is the rising incidence of end-stage heart failure and other severe cardiac conditions, which are creating an urgent demand for alternative treatment options as the global population ages. This trend is exacerbated by the chronic shortage of donor hearts, with waiting lists often spanning years and many patients succumbing before a suitable organ becomes available. As a result, artificial hearts are being increasingly adopted as either a bridge-to-transplant solution or as a destination therapy for patients who are not candidates for heart transplantation. Another critical driver is the rapid pace of innovation in bioengineering and material science, which is leading to the development of more durable, biocompatible, and efficient artificial heart models. These technological advancements are making artificial hearts safer and more accessible, thereby expanding their use beyond academic research centers to a broader range of healthcare facilities worldwide. Moreover, growing investments in research and development by both public and private sectors are accelerating the commercialization and clinical adoption of artificial hearts. Additionally, increased healthcare expenditure and rising awareness about advanced cardiac care options are encouraging hospitals to adopt these cutting-edge devices, further boosting market demand. The expansion of telemedicine and remote monitoring technologies is another factor enhancing the appeal of artificial hearts, as these solutions enable real-time tracking of device performance and patient health, reducing complications and improving overall patient management. Collectively, these drivers are propelling the growth of the artificial hearts market, positioning it as a critical component of the future of cardiovascular care and a beacon of hope for patients with severe cardiac ailments.

Select Competitors (Total 43 Featured) -

  • Abbott Laboratories, Inc.
  • Abiomed, Inc.
  • Artivion, Inc
  • Berlin Heart GmbH
  • BiVACOR, Inc.
  • Boston Scientific Corporation
  • Calon Cardio-Technology Ltd.
  • CARMAT
  • Edwards Lifesciences Corporation
  • Jarvik Heart, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Artificial Hearts - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Heart Failure Drives Demand for Advanced Artificial Heart Solutions
    • Here's the Story: How the Shortage of Donor Hearts Expands the Addressable Market for Artificial Hearts
    • Increasing Adoption of Artificial Hearts as Bridge-to-Transplant Options Propels Market Growth
    • Advancements in Biomaterials and Sensor Integration Strengthen Business Case for Next-Generation Artificial Hearts
    • Rising Geriatric Population Spurs Demand for Long-Term Artificial Heart Implants
    • Here's How Improvements in Battery Technology Generate Opportunities for Portable Artificial Hearts
    • Expansion of Minimally Invasive Surgical Techniques Drives Adoption of Compact and Efficient Artificial Heart Devices
    • Emphasis on Reducing Complications Sustains Growth in the Development of Thrombosis-Resistant Artificial Hearts
    • Focus on Patient-Specific Customization Creates New Growth Opportunities for Personalized Artificial Heart Devices
    • High Costs of Artificial Hearts Pose Challenges to Widespread Adoption in Cost-Sensitive Markets
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Artificial Hearts Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Artificial Hearts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Artificial Hearts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Artificial Hearts by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Left Ventricular Assist Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Left Ventricular Assist Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Left Ventricular Assist Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Total Artificial Heart by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Total Artificial Heart by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Total Artificial Heart by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Heart-Lung Machines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Heart-Lung Machines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Heart-Lung Machines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Artificial Hearts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 15: USA Historic Review for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: USA 16-Year Perspective for Artificial Hearts by Equipment Type - Percentage Breakdown of Value Sales for Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 17: Canada Recent Past, Current & Future Analysis for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 18: Canada Historic Review for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: Canada 16-Year Perspective for Artificial Hearts by Equipment Type - Percentage Breakdown of Value Sales for Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines for the Years 2014, 2024 & 2030
  • JAPAN
    • Artificial Hearts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Japan Historic Review for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: Japan 16-Year Perspective for Artificial Hearts by Equipment Type - Percentage Breakdown of Value Sales for Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines for the Years 2014, 2024 & 2030
  • CHINA
    • Artificial Hearts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 23: China Recent Past, Current & Future Analysis for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: China Historic Review for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: China 16-Year Perspective for Artificial Hearts by Equipment Type - Percentage Breakdown of Value Sales for Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines for the Years 2014, 2024 & 2030
  • EUROPE
    • Artificial Hearts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Artificial Hearts by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Artificial Hearts by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: Europe 16-Year Perspective for Artificial Hearts by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Europe 16-Year Perspective for Artificial Hearts by Equipment Type - Percentage Breakdown of Value Sales for Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines for the Years 2014, 2024 & 2030
  • FRANCE
    • Artificial Hearts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 32: France Recent Past, Current & Future Analysis for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: France Historic Review for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: France 16-Year Perspective for Artificial Hearts by Equipment Type - Percentage Breakdown of Value Sales for Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines for the Years 2014, 2024 & 2030
  • GERMANY
    • Artificial Hearts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 35: Germany Recent Past, Current & Future Analysis for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Germany Historic Review for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Germany 16-Year Perspective for Artificial Hearts by Equipment Type - Percentage Breakdown of Value Sales for Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 38: Italy Recent Past, Current & Future Analysis for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Italy Historic Review for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Italy 16-Year Perspective for Artificial Hearts by Equipment Type - Percentage Breakdown of Value Sales for Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Artificial Hearts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 41: UK Recent Past, Current & Future Analysis for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: UK Historic Review for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: UK 16-Year Perspective for Artificial Hearts by Equipment Type - Percentage Breakdown of Value Sales for Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 44: Spain Recent Past, Current & Future Analysis for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Spain Historic Review for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Spain 16-Year Perspective for Artificial Hearts by Equipment Type - Percentage Breakdown of Value Sales for Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 47: Russia Recent Past, Current & Future Analysis for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Russia Historic Review for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Russia 16-Year Perspective for Artificial Hearts by Equipment Type - Percentage Breakdown of Value Sales for Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Rest of Europe Historic Review for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Rest of Europe 16-Year Perspective for Artificial Hearts by Equipment Type - Percentage Breakdown of Value Sales for Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Artificial Hearts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Hearts by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Artificial Hearts by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Asia-Pacific 16-Year Perspective for Artificial Hearts by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Asia-Pacific 16-Year Perspective for Artificial Hearts by Equipment Type - Percentage Breakdown of Value Sales for Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Artificial Hearts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 59: Australia Recent Past, Current & Future Analysis for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Australia Historic Review for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Australia 16-Year Perspective for Artificial Hearts by Equipment Type - Percentage Breakdown of Value Sales for Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines for the Years 2014, 2024 & 2030
  • INDIA
    • Artificial Hearts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 62: India Recent Past, Current & Future Analysis for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: India Historic Review for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: India 16-Year Perspective for Artificial Hearts by Equipment Type - Percentage Breakdown of Value Sales for Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 65: South Korea Recent Past, Current & Future Analysis for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: South Korea Historic Review for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: South Korea 16-Year Perspective for Artificial Hearts by Equipment Type - Percentage Breakdown of Value Sales for Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Rest of Asia-Pacific Historic Review for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Rest of Asia-Pacific 16-Year Perspective for Artificial Hearts by Equipment Type - Percentage Breakdown of Value Sales for Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Artificial Hearts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Artificial Hearts by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Artificial Hearts by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Latin America 16-Year Perspective for Artificial Hearts by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Latin America 16-Year Perspective for Artificial Hearts by Equipment Type - Percentage Breakdown of Value Sales for Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 77: Argentina Recent Past, Current & Future Analysis for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Argentina Historic Review for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Argentina 16-Year Perspective for Artificial Hearts by Equipment Type - Percentage Breakdown of Value Sales for Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 80: Brazil Recent Past, Current & Future Analysis for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Brazil Historic Review for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Brazil 16-Year Perspective for Artificial Hearts by Equipment Type - Percentage Breakdown of Value Sales for Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 83: Mexico Recent Past, Current & Future Analysis for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Mexico Historic Review for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Mexico 16-Year Perspective for Artificial Hearts by Equipment Type - Percentage Breakdown of Value Sales for Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 86: Rest of Latin America Recent Past, Current & Future Analysis for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of Latin America Historic Review for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of Latin America 16-Year Perspective for Artificial Hearts by Equipment Type - Percentage Breakdown of Value Sales for Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Artificial Hearts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Artificial Hearts by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Artificial Hearts by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Middle East 16-Year Perspective for Artificial Hearts by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 92: Middle East Recent Past, Current & Future Analysis for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Middle East Historic Review for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Middle East 16-Year Perspective for Artificial Hearts by Equipment Type - Percentage Breakdown of Value Sales for Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 95: Iran Recent Past, Current & Future Analysis for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Iran Historic Review for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Iran 16-Year Perspective for Artificial Hearts by Equipment Type - Percentage Breakdown of Value Sales for Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 98: Israel Recent Past, Current & Future Analysis for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Israel Historic Review for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Israel 16-Year Perspective for Artificial Hearts by Equipment Type - Percentage Breakdown of Value Sales for Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 101: Saudi Arabia Recent Past, Current & Future Analysis for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Saudi Arabia Historic Review for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Saudi Arabia 16-Year Perspective for Artificial Hearts by Equipment Type - Percentage Breakdown of Value Sales for Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 104: UAE Recent Past, Current & Future Analysis for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: UAE Historic Review for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: UAE 16-Year Perspective for Artificial Hearts by Equipment Type - Percentage Breakdown of Value Sales for Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 107: Rest of Middle East Recent Past, Current & Future Analysis for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Rest of Middle East Historic Review for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Rest of Middle East 16-Year Perspective for Artificial Hearts by Equipment Type - Percentage Breakdown of Value Sales for Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines for the Years 2014, 2024 & 2030
  • AFRICA
    • Artificial Hearts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 110: Africa Recent Past, Current & Future Analysis for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Africa Historic Review for Artificial Hearts by Equipment Type - Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Africa 16-Year Perspective for Artificial Hearts by Equipment Type - Percentage Breakdown of Value Sales for Left Ventricular Assist Devices, Total Artificial Heart and Heart-Lung Machines for the Years 2014, 2024 & 2030

IV. COMPETITION